Zacks Investment Research on MSN3h
Is it Worth Retaining QIAGEN Stock in Your Portfolio Now?
QIAGEN N.V.’s QGEN fourth-quarter performance was driven by solid potential in molecular diagnostics. The company continues to progress with its test menu expansion, building a solid foundation to ...
Zacks Investment Research on MSN2d
Is MOD Stock a Buy Now on Buyback Plan and Expanded CDU Offerings?
Global leader in thermal management solutions Modine Manufacturing MOD recently gave its investors a reason to cheer by ...
Compugen (NASDAQ:CGEN) Downgraded to Hold Rating by StockNews.com
Compugen (NASDAQ:CGEN – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Separately, ...
StockNews.com Downgrades Blue Bird (NASDAQ:BLBD) to Hold
Blue Bird (NASDAQ:BLBD – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold ...